Accipere Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.80 M
- Paid Up Capital ₹ 0.60 M
- Company Age 9 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 62.08%
- Profit Growth 226.43%
- Ebitda -78.07%
- Net Worth 67.58%
- Total Assets 26.48%
About Accipere Pharmaceuticals
Accipere Pharmaceuticals Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 August 2015 (Nine years and six months 0 days old ). Its registered office is in Kollam, Kerala, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.80 M and a paid-up capital of Rs 0.60 M, as per Ministry of Corporate Affairs (MCA) records.
Sreejith Nair, Abhilash Nair, and Vinod Nair serve as directors at the Company.
Company Details
-
Location
Kollam, Kerala, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231KL2015PTC038947
-
Company No.
038947
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Aug 2015
-
Date of AGM
18 Dec 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Accipere Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhilash Nair
|
Managing Director | 04-Aug-2015 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Sreejith Nair
|
Director | 04-Aug-2015 | Current |
|
Vinod Nair
|
Director | 04-Aug-2015 | Current |
Financial Performance of Accipere Pharmaceuticals.
Accipere Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 62.08% increase. The company also saw a substantial improvement in profitability, with a 226.43% increase in profit. The company's net worth Soared by an impressive increase of 67.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Accipere Pharmaceuticals?
Unlock access to Accipere Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Accipere Pharmaceuticals?
Unlock and access historical data on people associated with Accipere Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Accipere Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Accipere Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.